Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Agnieszka Giza
Observed names:
A. Giza,
A. Gıza,
A., Giza,
Giza Agnieszka,
Giza, Agnieszka,
agnieszka giza
show all 6
Institutions:
Medical University of Lublin,
Jagiellonian University,
Szpital Uniwersytecki w Krakowie
Observed institutions:
Medical University of Lublin,
Jagiellonian University,
Huddersfield Royal Infirmary,
University Hospital Frankfurt,
Szpital Uniwersytecki w Krakowie,
Charité – Universitätsmedizin Berlin,
Ludwig-Maximilians-Universität München
show all 7
ORCID:
0009-0002-5741-3482
Observed ORCID:
0009-0002-5741-3482
OpenAlex ID:
A5058928859
Lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma (MCL-002; SPRINT): a phase 2, randomised, multicentre trial
2016
·
Marek Trněný
, Thierry Lamy
, et al.
·
The Lancet Oncology
·
173
Outcomes of treatment with dose‐adjusted EPOCH‐R or R‐CHOP in primary mediastinal large B‐cell lymphoma
2019
·
Agata Malenda
, Agnieszka Kołkowska‐Leśniak
, et al.
·
European Journal Of Haematology
·
42
First‐line R‐CVP versus R‐CHOP induction immunochemotherapy for indolent lymphoma with rituximab maintenance. A multicentre, phase III randomized study by the Polish Lymphoma Research Group PLRG4
2019
·
Jan Walewski
, Ewa Paszkiewicz‐Kozik
, et al.
·
British Journal of Haematology
·
30
PDF
Type 2 diabetes mellitus compromises the survival of diffuse large B-cell lymphoma patients treated with (R)-CHOP – the PLRG report
2020
·
Joanna Drozd-Sokolowska
, Jan Maciej Zaucha
, et al.
·
Scientific Reports
·
23
Efficacy of radioimmunotherapy with (90Y) ibritumomab tiuxetan is superior as consolidation in relapsed or refractory mantle cell lymphoma: Results of two phase II trials of the European MCL Network and the PLRG
2006
·
O. Weigert
, W. Jurczak
, et al.
·
Journal of Clinical Oncology
·
22
The predictive role of interim PET after the first chemotherapy cycle and sequential evaluation of response to ABVD in Hodgkin’s lymphoma patients—the Polish Lymphoma Research Group (PLRG) Observational Study
2017
·
J.M. Zaucha
, B. Małkowski
, et al.
·
Annals of Oncology
·
20
Macrocytosis during sunitinib treatment predicts progression-free survival in patients with metastatic renal cell carcinoma
2016
·
Jakub Kucharz
, Agnieszka Giza
, et al.
·
Medical Oncology
·
17
PDF
90Y-Zevalin® (90Y-Ibritumomab Tiuxetan) Radioimmunotherapy (RIT) Consolidation of FCM Induction Chemotherapy in Mantle Cell Lymphoma (MCL) Patients: Results from the PLRG upon Completed Enrollment.
2006
·
Wojciech Jurczak
, A. Giza
, et al.
·
Blood
·
17
Polish Lymphoma Research Group Experience With Bexarotene in the Treatment of Cutaneous T-Cell Lymphoma
2014
·
Malgorzata Sokolowska-Wojdylo
, Aleksandra Florek
, et al.
·
American Journal of Therapeutics
·
16
Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) with probable mesentery involvement with associated hemophagocytic syndrome (HPS) – how to treat it?
2020
·
Agnieszka Giza
, Krystyna Gałązka
, et al.
·
Journal of Dermatological Treatment
·
12
Liposomal cytarabine in the prophylaxis and treatment of CNS lymphoma: toxicity analysis in a retrospective case series study conducted at Polish Lymphoma Research Group Centers
2015
·
Wojciech Jurczak
, Renata Kroll-Balcerzak
, et al.
·
Medical Oncology
·
12
PDF
Radiological Response and Neutrophil-to-Lymphocyte Ratio as Predictive Factors for Progression-Free and Overall Survival in Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib
2019
·
Jakub Kucharz
, Paulina Dumnicka
, et al.
·
Advances in experimental medicine and biology
·
11
Hodgkin lymphoma of the elderly patients: a retrospective multicenter analysis from the Polish Lymphoma Research Group*
2018
·
Tomasz Wróbel
, Przemysław Biecek
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
10
Primary Renal Lymphoma: Report of 32 Cases—A Retrospective Multicenter PLRG Analysis
2025
·
Magdalena Witkowska
, Joanna Romejko-Jarosińska
, et al.
·
Biomedicines
·
9
PDF
Consolidation with90Y ibritumomab tiuxetan radioimmunotherapy in mantle cell lymphoma patients ineligible for high dose therapy: results of the phase II multicentre Polish Lymphoma Research Group trial, after 8-year long follow-up
2019
·
Wojciech Jurczak
, Alicja M. Gruszka
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
9
Role of rituximab in the first-line therapy of high-risk diffuse large B-cell lymphoma: a retrospective analysis by the Polish Lymphoma Research Group
2015
·
Wojciech Jurczak
, Bogdan Ochrem
, et al.
·
Polskie Archiwum Medycyny Wewnętrznej
·
9
PDF
A survey across orbital lymphoma in Poland: Multicenter retrospective study of polish lymphoma research group ( PLRG )
2022
·
Elżbieta Kalicińska
, Agnieszka Giza
, et al.
·
Cancer Medicine
·
8
Comparison of two doses of intravenous temsirolimus in patients with relapsed/refractory mantle cell lymphoma
2017
·
Wojciech Jurczak
, Sundra Ramanathan
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
8
PDF
Early efficacy and safety of obinutuzumab with chemotherapy in previously untreated patients with follicular lymphoma: A real-world retrospective report of the Polish Lymphoma Research Group
2023
·
Ewa Paszkiewicz-Kozik
, Iwona Hus
, et al.
·
Advances in Clinical and Experimental Medicine
·
7
PDF
Primary cutaneous lymphomas. Diagnostic and therapeutic guidelines of the Polish Dermatological Society (PTD) and Polish Lymphoma Research Group (PLRG)
2023
·
Małgorzata Sokołowska-Wojdyło
, Berenika Olszewska
, et al.
·
Dermatology Review
·
7
Post-transplant Lymphoproliferative Disorder in a Patient After Kidney Transplant, 5-Year Follow-up: A Case Report
2020
·
Ewa Ignacak
, Joanna Sułowicz
, et al.
·
Transplantation Proceedings
·
7
PDF
Primary mediastinal B-cell lymphoma – metabolic and anatomical features in 18FDG-PET/CT and response to therapy
2016
·
Anna Kocurek
, Bogdan Małkowski
, et al.
·
Współczesna Onkologia
·
7
PDF
New forms of radionuclide therapy with (90)Y in oncology.
2008
·
Alicja Hubalewska-Dydejczyk
, Wojciech Jurczak
, et al.
·
PubMed
·
7
PDF
T021: Radiation-Free Therapy as the INitial treatment of Good-prognosis early non-bulky Hodgkin lymphoma, defined by a low Metabolic Tumor Volume and a negative PET-2 - RAFTING Trial.
2022
·
Andrea Gallamini
, Marco Picardi
, et al.
·
HemaSphere
·
6
Design, Synthesis and Biological Activity of New Amides Derived from 3‐Benzhydryl and 3‐sec‐Butyl‐2,5‐dioxo‐pyrrolidin‐1‐yl‐acetic Acid
2021
·
Małgorzata Góra
, Anna Czopek
, et al.
·
ChemMedChem
·
6
Show more works
View as search
Works count:
105
Citation count:
574
H-index:
11
I10-index:
13
Year
Topic
Type